CSPC Pharmaceutical Group ( 01093.HK ) Executive Director and Chairman Cai Dongchen increased his holdings by 49.4 million shares

2026-03-29 00:19:26

Gelonghui, March 26丨According to the latest equity disclosure information from the Hong Kong Stock Exchange, on March 26, 2026, CSPC Pharmaceutical Group (01093.HK) was increased by Executive Director and Chairman Cai Dongchen, who purchased 49.4 million shares at an average price of HK$8.3612 per share, involving approximately HK$41.94 million.

After the increase, Cai Dongchen’s latest shareholding is 2,966,304,670 shares, with the shareholding percentage rising from 25.31% to 25.74%.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes